Half-year report · Q2
7681.TEDINET S100VQVP
Period2024-10-01 → 2025-03-31
Filed2025-05-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥12.9bn | 2024-10-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥19.8bn | 2023-10-01 → 2024-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥12.2bn | 2023-10-01 → 2024-03-31 | Cons. | Net sales |
| Operating income | ¥497m | 2024-10-01 → 2025-03-31 | Cons. | Operating income |
| Operating income | ¥358m | 2023-10-01 → 2024-03-31 | Cons. | Operating income |
| Ordinary income | ¥514m | 2024-10-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥181m | 2023-10-01 → 2024-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥358m | 2023-10-01 → 2024-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥514m | 2024-10-01 → 2025-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥358m | 2023-10-01 → 2024-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥344m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥136m | 2023-10-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥221m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥356m | 2024-10-01 → 2025-03-31 | Cons. | Profit loss |
| Net income | ¥229m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss |
| Total assets | ¥16.1bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥10.7bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥13.5bn | at 2024-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥10.2bn | at 2025-03-31 | Cons. | Liabilities |
| Total liabilities | ¥4.9bn | at 2024-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥6.0bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥5.7bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥5.9bn | at 2024-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥5.3bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥5.6bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥5.2bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.6bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.9bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.5bn | at 2023-09-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥87m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥33m | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥521m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥123m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥101m | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥23m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥105m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥97m | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥100m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥58.32 | 2024-10-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.09 | 2023-10-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥37.49 | 2023-10-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥58.08 | 2024-10-01 → 2025-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥22.96 | 2023-10-01 → 2024-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥37.26 | 2023-10-01 → 2024-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 36.0% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.3% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.2% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 26
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2024-10-01 → 2025-03-31 | ¥1m |
| jpcrp040300-q2r_E34455-000Food Servicereportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥193m |
| jpcrp040300-q2r_E34455-000Food Servicereportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥193m |
| jpcrp040300-q2r_E34455-000Food Servicereportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥2m |
| jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥410m |
| jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥410m |
| jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥41m |
| jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥12.3bn |
| jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥12.3bn |
| jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥453m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-10-01 → 2025-03-31 | ¥12.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-10-01 → 2025-03-31 | ¥12.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-10-01 → 2025-03-31 | ¥496m |
| Reconciling Itemsreconciling | segment profit | 2023-10-01 → 2024-03-31 | ¥1m |
| jpcrp040300-q2r_E34455-000Food Servicereportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥211m |
| jpcrp040300-q2r_E34455-000Food Servicereportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥211m |
| jpcrp040300-q2r_E34455-000Food Servicereportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥7m |
| jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥372m |
| jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥372m |
| jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥31m |
| jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥11.6bn |
| jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥11.6bn |
| jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥319m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-10-01 → 2024-03-31 | ¥12.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-10-01 → 2024-03-31 | ¥12.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-10-01 → 2024-03-31 | ¥357m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 480
| Item | Context | Value | Unit |
|---|---|---|---|
| Cash dividends paid fin cf | Prior1YTDDuration | -97900000 | JPY |
| Cash dividends paid fin cf | CurrentYTDDuration | -98349000 | JPY |
| Dividends paid to non controlling interests fin cf | Prior1YTDDuration | -4500000 | JPY |
| Dividends paid to non controlling interests fin cf | CurrentYTDDuration | -6000000 | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | -99632000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | -105444000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | 398326000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | -316022000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 5517421000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 5554031000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 5915747000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 5238009000 | JPY |
| Salaries and allowances sga | Prior1YTDDuration | 496772000 | JPY |
| Salaries and allowances sga | CurrentYTDDuration | 472852000 | JPY |
| Provision for bonuses sga | Prior1YTDDuration | 95246000 | JPY |
| Provision for bonuses sga | CurrentYTDDuration | 92592000 | JPY |
| Provision for directors bonuses sga | Prior1YTDDuration | 8400000 | JPY |
| Provision for directors bonuses sga | CurrentYTDDuration | 8400000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 18597000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 18011000 | JPY |
| Provision for directors retirement benefits sga | Prior1YTDDuration | 27875000 | JPY |
| Provision for directors retirement benefits sga | CurrentYTDDuration | 16141000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1YTDDuration | -34000 | JPY |
| Provision of allowance for doubtful accounts sga | CurrentYTDDuration | 831000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E34455-000TotalMedicalSolutionBusinessReportableSegmentMember | 11633398000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E34455-000RemoteImageDiagnosisServiceBusinessReportableSegmentMember | 372464000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E34455-000FoodServiceReportableSegmentMember | 210815000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 12216679000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 12216679000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E34455-000TotalMedicalSolutionBusinessReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E34455-000RemoteImageDiagnosisServiceBusinessReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E34455-000FoodServiceReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E34455-000TotalMedicalSolutionBusinessReportableSegmentMember | 11633398000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E34455-000RemoteImageDiagnosisServiceBusinessReportableSegmentMember | 372464000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E34455-000FoodServiceReportableSegmentMember | 210815000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 12216679000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Net sales | Prior1YTDDuration | 12216679000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E34455-000TotalMedicalSolutionBusinessReportableSegmentMember | 318654000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E34455-000RemoteImageDiagnosisServiceBusinessReportableSegmentMember | 30901000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E34455-000FoodServiceReportableSegmentMember | 7262000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 356818000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | 1180000 | JPY |
| Operating income | Prior1YTDDuration | 357998000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E34455-000TotalMedicalSolutionBusinessReportableSegmentMember | 12337563000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E34455-000RemoteImageDiagnosisServiceBusinessReportableSegmentMember | 409731000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |